1. Home
  2. GPMT vs TLSI Comparison

GPMT vs TLSI Comparison

Compare GPMT & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPMT
  • TLSI
  • Stock Information
  • Founded
  • GPMT 2015
  • TLSI 2010
  • Country
  • GPMT United States
  • TLSI United States
  • Employees
  • GPMT N/A
  • TLSI N/A
  • Industry
  • GPMT Real Estate Investment Trusts
  • TLSI Medical Specialities
  • Sector
  • GPMT Real Estate
  • TLSI Health Care
  • Exchange
  • GPMT Nasdaq
  • TLSI Nasdaq
  • Market Cap
  • GPMT 149.5M
  • TLSI 124.9M
  • IPO Year
  • GPMT 2017
  • TLSI N/A
  • Fundamental
  • Price
  • GPMT $2.94
  • TLSI $4.05
  • Analyst Decision
  • GPMT Buy
  • TLSI Strong Buy
  • Analyst Count
  • GPMT 4
  • TLSI 6
  • Target Price
  • GPMT $4.58
  • TLSI $11.75
  • AVG Volume (30 Days)
  • GPMT 383.1K
  • TLSI 54.4K
  • Earning Date
  • GPMT 02-12-2025
  • TLSI 11-14-2024
  • Dividend Yield
  • GPMT 6.83%
  • TLSI N/A
  • EPS Growth
  • GPMT N/A
  • TLSI N/A
  • EPS
  • GPMT N/A
  • TLSI N/A
  • Revenue
  • GPMT N/A
  • TLSI $26,891,000.00
  • Revenue This Year
  • GPMT N/A
  • TLSI $60.97
  • Revenue Next Year
  • GPMT N/A
  • TLSI $53.69
  • P/E Ratio
  • GPMT N/A
  • TLSI N/A
  • Revenue Growth
  • GPMT N/A
  • TLSI 67.90
  • 52 Week Low
  • GPMT $2.46
  • TLSI $3.50
  • 52 Week High
  • GPMT $6.41
  • TLSI $10.42
  • Technical
  • Relative Strength Index (RSI)
  • GPMT 31.68
  • TLSI 49.84
  • Support Level
  • GPMT $3.28
  • TLSI $3.60
  • Resistance Level
  • GPMT $3.42
  • TLSI $4.17
  • Average True Range (ATR)
  • GPMT 0.14
  • TLSI 0.37
  • MACD
  • GPMT -0.06
  • TLSI -0.03
  • Stochastic Oscillator
  • GPMT 2.65
  • TLSI 42.31

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning, and repurposing of the property.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: